Figure 1.
Time to tumor recurrence (A) and overall survival (B) by T-A, C-A, and T-G haplotypes of CD44 rs187115 and rs187116 polymorphisms in localized gastric adenocarcinoma patients. All censored patients and those who showed tumor recurrence are accounted for.